StockData
Natures Sunshine Products Inc logo

Natures Sunshine Products Inc (NATR) stock

NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3057% below fair value
$10.56+0.20 (+1.93%)

Close on Nov 16, 2026Market cap $185.81MP/E 10.5Yield –

Natures Sunshine Products ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Natures Sunshine Products's ebitda for the twelve months ending Jun 30, 2026 was $42.69M, up 22.5% year over year. For fiscal 2025 it was $38.59M, up 12.5% from the year before. Over ten years it grew 7.7% a year on average. The highest annual figure on record is $45.83M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$38.59M+12.5%
FY2024Dec 31, 2024$34.31M+12.3%
FY2023Dec 31, 2023$30.57M+12.0%
FY2022Dec 31, 2022$27.28M-40.5%
FY2021Dec 31, 2021$45.83M+42.2%
FY2020Dec 31, 2020$32.23M+20.6%
FY2019Dec 31, 2019$26.72M+76.3%
FY2018Dec 31, 2018$15.16M+51.3%
FY2017Dec 31, 2017$10.02M-32.5%
FY2016Dec 31, 2016$14.85M-19.3%
FY2015Dec 31, 2015$18.40M-21.6%
FY2014Dec 31, 2014$23.46M-16.4%
FY2013Dec 31, 2013$28.05M-26.1%
FY2012Dec 31, 2012$37.94M+54.7%
FY2011Dec 31, 2011$24.53M+58.1%
FY2010Dec 31, 2010$15.52M-8.4%
FY2009Dec 31, 2009$16.93M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.78M+13.0%
Q1 FY2026Mar 31, 2026$12.77M+32.0%
Q4 FY2025Dec 31, 2025$8.63M+0.6%
Q3 FY2025Sep 30, 2025$12.51M+41.9%
Q2 FY2025Jun 30, 2025$7.77M-14.9%
Q1 FY2025Mar 31, 2025$9.67M+24.2%
Q4 FY2024Dec 31, 2024$8.57M-2.1%
Q3 FY2024Sep 30, 2024$8.82M-1.5%
Q2 FY2024Jun 30, 2024$9.14M-7.4%
Q1 FY2024Mar 31, 2024$7.78M+161.5%
Q4 FY2023Dec 31, 2023$8.76M+23.5%
Q3 FY2023Sep 30, 2023$8.96M+16.7%
Q2 FY2023Jun 30, 2023$9.87M+16.9%
Q1 FY2023Mar 31, 2023$2.98M-26.9%
Q4 FY2022Dec 31, 2022$7.10M-32.0%
Q3 FY2022Sep 30, 2022$7.67M-39.8%
Q2 FY2022Jun 30, 2022$8.44M-31.3%
Q1 FY2022Mar 31, 2022$4.08M-60.7%
Q4 FY2021Dec 31, 2021$10.43M+102.2%
Q3 FY2021Sep 30, 2021$12.74M+54.7%
Q2 FY2021Jun 30, 2021$12.29M+35.5%
Q1 FY2021Mar 31, 2021$10.37M+6.2%
Q4 FY2020Dec 31, 2020$5.16M-26.0%
Q3 FY2020Sep 30, 2020$8.24M+13.6%
Q2 FY2020Jun 30, 2020$9.07M+29.0%
Q1 FY2020Mar 31, 2020$9.76M+78.4%
Q4 FY2019Dec 31, 2019$6.97M+451.7%
Q3 FY2019Sep 30, 2019$7.25M+24.6%
Q2 FY2019Jun 30, 2019$7.03M+52.9%
Q1 FY2019Mar 31, 2019$5.47M+57.2%
Q4 FY2018Dec 31, 2018$1.26M–
Q3 FY2018Sep 30, 2018$5.81M+26.3%
Q2 FY2018Jun 30, 2018$4.60M+113.1%
Q1 FY2018Mar 31, 2018$3.48M-0.6%
Q4 FY2017Dec 31, 2017-$243.00K–
Q3 FY2017Sep 30, 2017$4.61M-26.6%
Q2 FY2017Jun 30, 2017$2.16M–
Q1 FY2017Mar 31, 2017$3.50M–
Q4 FY2016Dec 31, 2016-$189.00K–
Q3 FY2016Sep 30, 2016$6.27M–

More Natures Sunshine Products figures

See a number that looks wrong?